Goldman Sachs’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $432M | Sell |
1,476,183
-84,249
| -5% | -$27.7M | 0.05% | 393 |
|
|
2025
Q4 | $547M | Buy |
1,560,432
+148,443
| +11% | +$50.2M | 0.07% | 274 |
|
|
2025
Q3 | $456M | Buy |
1,411,989
+18,163
| +1% | +$5.65M | 0.06% | 330 |
|
|
2025
Q2 | $542M | Buy |
1,393,826
+119,423
| +9% | +$48M | 0.07% | 257 |
|
|
2025
Q1 | $554M | Sell |
1,274,403
-16,827
| -1% | -$6.75M | 0.09% | 223 |
|
|
2024
Q4 | $476M | Sell |
1,291,230
-704,292
| -35% | -$295M | 0.08% | 240 |
|
|
2024
Q3 | $1.04B | Buy |
1,995,522
+83,705
| +4% | +$44.7M | 0.17% | 104 |
|
|
2024
Q2 | $1.04B | Buy |
1,911,817
+47,949
| +3% | +$25.3M | 0.18% | 100 |
|
|
2024
Q1 | $966M | Sell |
1,863,868
-274,047
| -13% | -$136M | 0.17% | 105 |
|
|
2023
Q4 | $1.01B | Buy |
2,137,915
+97,107
| +5% | +$44.9M | 0.19% | 92 |
|
|
2023
Q3 | $889M | Buy |
2,040,808
+27,400
| +1% | +$12.4M | 0.19% | 95 |
|
|
2023
Q2 | $895M | Buy |
2,013,408
+170,785
| +9% | +$78.8M | 0.19% | 85 |
|
|
2023
Q1 | $847M | Sell |
1,842,623
-215,911
| -10% | -$103M | 0.19% | 89 |
|
|
2022
Q4 | $1.06B | Sell |
2,058,534
-168,336
| -8% | -$85.5M | 0.26% | 59 |
|
|
2022
Q3 | $1.01B | Buy |
2,226,870
+120,066
| +6% | +$57.4M | 0.26% | 58 |
|
|
2022
Q2 | $1.02B | Buy |
2,106,804
+556,209
| +36% | +$275M | 0.25% | 59 |
|
|
2022
Q1 | $762M | Buy |
1,550,595
+226,437
| +17% | +$104M | 0.16% | 100 |
|
|
2021
Q4 | $614M | Buy |
1,324,158
+401,016
| +43% | +$169M | 0.12% | 149 |
|
|
2021
Q3 | $344M | Sell |
923,142
-337,827
| -27% | -$128M | 0.07% | 249 |
|
|
2021
Q2 | $481M | Sell |
1,260,969
-427,183
| -25% | -$163M | 0.11% | 164 |
|
|
2021
Q1 | $606M | Buy |
1,688,152
+330,308
| +24% | +$106M | 0.15% | 111 |
|
|
2020
Q4 | $436M | Sell |
1,357,844
-143,309
| -10% | -$44M | 0.11% | 162 |
|
|
2020
Q3 | $403M | Sell |
1,501,153
-253,430
| -14% | -$68.2M | 0.11% | 154 |
|
|
2020
Q2 | $461M | Sell |
1,754,583
-84,060
| -5% | -$22.4M | 0.14% | 132 |
|
|
2020
Q1 | $417M | Sell |
1,838,643
-632,042
| -26% | -$172M | 0.15% | 126 |
|
|
2019
Q4 | $746M | Sell |
2,470,685
-69,595
| -3% | -$19.2M | 0.19% | 92 |
|
|
2019
Q3 | $610M | Buy |
2,540,280
+263,857
| +12% | +$72.3M | 0.18% | 97 |
|
|
2019
Q2 | $642M | Buy |
2,276,423
+284,621
| +14% | +$77.7M | 0.18% | 91 |
|
|
2019
Q1 | $572M | Buy |
1,991,802
+448,018
| +29% | +$130M | 0.17% | 97 |
|
|
2018
Q4 | $405M | Sell |
1,543,784
-248,551
| -14% | -$68.3M | 0.13% | 130 |
|
|
2018
Q3 | $491M | Sell |
1,792,335
-214,873
| -11% | -$55.8M | 0.13% | 145 |
|
|
2018
Q2 | $478M | Sell |
2,007,208
-817,088
| -29% | -$189M | 0.13% | 141 |
|
|
2018
Q1 | $620M | Sell |
2,824,296
-560,429
| -17% | -$132M | 0.16% | 113 |
|
|
2017
Q4 | $762M | Buy |
3,384,725
+905,807
| +37% | +$193M | 0.18% | 85 |
|
|
2017
Q3 | $471M | Buy |
2,478,918
+257,810
| +12% | +$49.1M | 0.12% | 152 |
|
|
2017
Q2 | $418M | Buy |
2,221,108
+7,603
| +0.3% | +$1.37M | 0.11% | 166 |
|
|
2017
Q1 | $366M | Buy |
2,213,505
+28,590
| +1% | +$4.55M | 0.1% | 184 |
|
|
2016
Q4 | $314M | Buy |
2,184,915
+402,963
| +23% | +$54M | 0.09% | 213 |
|
|
2016
Q3 | $223M | Buy |
1,781,952
+103,666
| +6% | +$13.4M | 0.07% | 301 |
|
|
2016
Q2 | $220M | Sell |
1,678,286
-108,126
| -6% | -$14.8M | 0.07% | 310 |
|
|
2016
Q1 | $248M | Buy |
1,786,412
+297,059
| +20% | +$39.7M | 0.08% | 259 |
|
|
2015
Q4 | $208M | Buy |
1,489,353
+106,214
| +8% | +$14.6M | 0.07% | 336 |
|
|
2015
Q3 | $194M | Buy |
1,383,139
+31,836
| +2% | +$4.78M | 0.07% | 318 |
|
|
2015
Q2 | $222M | Sell |
1,351,303
-269,937
| -17% | -$43.1M | 0.07% | 314 |
|
|
2015
Q1 | $250M | Sell |
1,621,240
-216,262
| -12% | -$30.8M | 0.08% | 267 |
|
|
2014
Q4 | $231M | Buy |
1,837,502
+200,139
| +12% | +$24.7M | 0.07% | 304 |
|
|
2014
Q3 | $196M | Buy |
1,637,363
+103,699
| +7% | +$11.9M | 0.06% | 342 |
|
|
2014
Q2 | $165M | Buy |
1,533,664
+288,806
| +23% | +$29.8M | 0.05% | 436 |
|
|
2014
Q1 | $124M | Sell |
1,244,858
-376,851
| -23% | -$34.1M | 0.04% | 524 |
|
|
2013
Q4 | $150M | Buy |
1,621,709
+864,296
| +114% | +$76.8M | 0.05% | 443 |
|
|
2013
Q3 | $63.3M | Sell |
757,413
-106,818
| -12% | -$9.15M | 0.02% | 825 |
|
|
2013
Q2 | $70.7M | Buy |
+864,231
| New | +$64.7M | 0.03% | 704 |
|
Other funds holding ELV
VCM
VPM
Goldman Sachs's ELV Position: Q1 2026 in Review
Goldman Sachs reduced its Elevance Health (ELV) stake by 5.4% in Q1 2026, selling an estimated $27.7M and leaving 1,476,183 shares worth $432M. The position accounts for 0.05% of the portfolio, ranked #393.
Goldman Sachs first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.06B in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Goldman Sachs held 1,476,183 shares of Elevance Health worth $432M as of Q1 2026.
- Goldman Sachs sold 84,249 Elevance Health shares in Q1 2026, an estimated $27.7M.
- Elevance Health made up 0.05% of Goldman Sachs's portfolio in Q1 2026, its #393 holding.
- Goldman Sachs first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Elevance Health position peaked at $1.06B in Q4 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.